Patent · US Expired

Unique T-lymphocyte line and products derived therefrom

US4438032A · kind A · utility

94Cited by

1References

22Claims

0Family size

Assignee

The Regents of the University of California · US

Inventors

David W. Golde · New York, US
Shirley G. Quan · Los Angeles, US

Key dates

Filing date	Jan 6, 1983
Grant date	Mar 20, 1984
Priority date	—
Expiry date	Jan 6, 2003

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S530/838
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Human T-lymphoblast cell line, Proteinaceous products produced therefrom, messenger RNA and DNA expressing the proteinaceous products. A human T-lymphoblast cell line (Mo) maintained as a continuous culture constitutively produces proteins, including immune interferon, neutrophil migration inhibition factor, granulocyte-macrophage colony-stimulating activity and erythroid-potentiating activity, as well as other proteins produced by T-cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.